Document Detail


Leucine as a pharmaconutrient to prevent and treat sarcopenia and type 2 diabetes.
MedLine Citation:
PMID:  22029833     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Amino acids function as precursors for de novo protein synthesis. In addition, however, they play a key role as nutritional signals that regulate multiple cellular processes. There is ample in vitro and in vivo evidence showing that muscle tissue responds to increases in amino acid availability via signal transduction pathways that are also regulated by insulin, glucagon, growth hormone, and insulin growth factor 1. The increased amino acid availibility results in the upregulation of mRNA translation, thereby increasing muscle protein synthesis, which, in turn, leads to greater net muscle protein accretion. These findings have been particularly pronounced for the amino acid leucine. Furthermore, leucine has the ability to act as a strong insulin secretagogue. Consequently, it has been suggested that leucine represents an effective pharmaconutrient for the prevention and treatment of sarcopenia and type 2 diabetes. In accordance, recent in vivo studies in humans show that free leucine ingestion can reverse the blunted response of muscle protein synthesis to amino acid/protein intake in the elderly. Although short-term studies suggest that leucine supplementation can stimulate muscle mass accretion in the elderly, there are no long-term nutritional intervention studies to confirm this or the other proposed benefits of leucine as a pharmaconutrient.
Authors:
Marika Leenders; Luc Jc van Loon
Related Documents :
787003 - Six-hour pigmentation test for the identification of cryptococcus neoformans.
19838713 - Acid-base regulatory ability of the cephalopod (sepia officinalis) in response to envir...
24493053 - Increased mobility induced by addition of a lewis acid to a lewis basic conjugated poly...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nutrition reviews     Volume:  69     ISSN:  1753-4887     ISO Abbreviation:  Nutr. Rev.     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-10-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376405     Medline TA:  Nutr Rev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  675-89     Citation Subset:  IM    
Copyright Information:
© 2011 International Life Sciences Institute.
Affiliation:
Top Institute Food and Nutrition (TIFN), Wageningen, the Netherlands, and the Department of Human Movement Sciences, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Maastricht University Medical Centre, Maastricht, the Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Economic incentives and nutritional behavior of children in the school setting: A systematic review.
Next Document:  CO2 Capture from the Atmosphere and Simultaneous Concentration using Zeolites and Amine Grafted SBA-...